Francesco Travaglino

Author

Azienda Ospedaliera Sant'Andrea ORCID

Also Known As

F Travaglino, F. Travaglino, Francesco TRAVAGLINO, Francesco Travaglino

Publications

454

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera Sant'Andrea Università Campus Bio-Medico University of Parma Sapienza University of Rome

About

Francesco Travaglino is an author at Azienda Ospedaliera Sant'Andrea specializing in medicine, cardiovascular disease, and sepsis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	126
2	Emergency Medicine	2	2	88
3	Public Health	1	1	38
4	Hospital Medicine	1	1	35
5	Pulmonary Medicine	1	1	35

Francesco Travaglino

Publications

371

Citations

H-Index

Page 1

	Year	Citations
Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department L. Magrini, G Gagliano, Francesco Travaglino, Clinical Chemistry and Laboratory Medicine (CCLM)	2014	102
Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score Francesco Travaglino, Benedetta De Berardinis, L. Magrini, BMC Infectious Diseases	2012	59
Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department Salvatore Di Somma, L. Magrini, Francesco Travaglino, Clinical Chemistry and Laboratory Medicine (CCLM) Heart FailureOpinion PaperPathogen DetectionInflammationBiomarker (Medicine)	2013	53
Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases. L. Magrini, Francesco Travaglino, Rossella Marino, PubMed	2013	42
High value of mid‐regional proadrenomedullin in COVID‐19: A marker of widespread endothelial damage, disease severity, and mortality Silvia Spoto, Felice Eugenio Agrò, Federica Sambuco, Journal of Medical Virology Acute Lung InjuryRespiratory Distress Syndrome (Pulmonary Critical Care)Vascular LeakageCovid-19Inflammatory Marker	2020	38
Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial Francesco Travaglino, Veronica Russo, Benedetta De Berardinis, The American Journal of Emergency Medicine In-hospital ProcalcitoninVeryfing Dyspnea TrialCardiovascular DiseaseMid-regional Pro-adrenomedullin TestingPulmonary Medicine	2014	35
COVID‐19 sniffer dog experimental training: Which protocol and which implications for reliable sidentification? Silvia Angeletti, Francesco Travaglino, Silvia Spoto, Journal of Medical Virology	2021	18
Role of biomarkers in patients with dyspnea. Gori Cs, L. Magrini, Francesco Travaglino, PubMed	2011	14
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients* Moises Muley, Panaiotis Finamore, Claudio Pedone, Critical Care Medicine	2022	10

Page 1